BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 28125698)

  • 21. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
    Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.
    Kong FM; Frey KA; Quint LE; Ten Haken RK; Hayman JA; Kessler M; Chetty IJ; Normolle D; Eisbruch A; Lawrence TS
    J Clin Oncol; 2007 Jul; 25(21):3116-23. PubMed ID: 17634490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
    Zhong H; Siddiqui SM; Movsas B; Chetty IJ
    Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.
    Fleckenstein J; Hellwig D; Kremp S; Grgic A; Gröschel A; Kirsch CM; Nestle U; Rübe C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e283-9. PubMed ID: 21470782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer.
    Yap ML; Sun A; Higgins J; Clarke K; Marshall A; Becker N; Le LW; Vines DC; Bezjak A; Bissonnette JP
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e199-e205. PubMed ID: 27637725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
    Willner J; Jost A; Baier K; Flentje M
    Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer.
    Siva S; Thomas R; Callahan J; Hardcastle N; Pham D; Kron T; Hicks RJ; MacManus MP; Ball DL; Hofman MS
    Radiother Oncol; 2015 May; 115(2):157-62. PubMed ID: 25935743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.
    Meijer G; Steenhuijsen J; Bal M; De Jaeger K; Schuring D; Theuws J
    Radiother Oncol; 2011 Sep; 100(3):396-401. PubMed ID: 21955663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of the anatomic changes and dosimetric consequences in adaptive CRT of non-small-cell lung cancer using deformable CT and CBCT image registration.
    Ma C; Hou Y; Li H; Li D; Zhang Y; Chen S; Yin Y
    Technol Cancer Res Treat; 2014 Apr; 13(2):95-100. PubMed ID: 23919391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.
    Wanet M; Delor A; Hanin FX; Ghaye B; Van Maanen A; Remouchamps V; Clermont C; Goossens S; Lee JA; Janssens G; Bol A; Geets X
    Strahlenther Onkol; 2017 Oct; 193(10):812-822. PubMed ID: 28733723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of non small cell lung cancer.
    Miao J; Yan H; Tian Y; Ma P; Liu Z; Li M; Ren W; Chen J; Zhang Y; Dai J
    J Appl Clin Med Phys; 2017 Nov; 18(6):169-176. PubMed ID: 29024297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing a 4D-CT lung function related volumetric dose model to reduce radiation pneumonia.
    Liu C; Liu H; Li Y; Xiao Z; Wang Y; Guo H; Luo J
    Sci Rep; 2024 Jun; 14(1):12589. PubMed ID: 38824238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.
    Nkhali L; Thureau S; Edet-Sanson A; Doyeux K; Benyoucef A; Gardin I; Michel P; Vera P; Dubray B
    Acta Oncol; 2015 Jun; 54(6):909-15. PubMed ID: 25417733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients.
    Kamran SC; Mueller BS; Paetzold P; Dunlap J; Niemierko A; Bortfeld T; Willers H; Craft D
    Radiother Oncol; 2016 Mar; 118(3):515-20. PubMed ID: 26830694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
    Vinod SK; Kumar S; Holloway LC; Shafiq J
    J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors.
    Simeonova A; Abo-Madyan Y; El-Haddad M; Welzel G; Polednik M; Boggula R; Wenz F; Lohr F
    Radiother Oncol; 2012 Feb; 102(2):268-73. PubMed ID: 22100654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer.
    Manon RR; Jaradat H; Patel R; Zhang T; Fenwick J; Tome W; Fowler J; Paliwal B; Soisson E; Yuan Z; Mehta M
    Clin Lung Cancer; 2005 Sep; 7(2):107-13. PubMed ID: 16179097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes.
    Even AJ; van der Stoep J; Zegers CM; Reymen B; Troost EG; Lambin P; van Elmpt W
    Radiother Oncol; 2015 Aug; 116(2):281-6. PubMed ID: 26238010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).
    Erdi YE; Rosenzweig K; Erdi AK; Macapinlac HA; Hu YC; Braban LE; Humm JL; Squire OD; Chui CS; Larson SM; Yorke ED
    Radiother Oncol; 2002 Jan; 62(1):51-60. PubMed ID: 11830312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.